Explore our materials

Andean Pacific Workshop on HIV & Hepatitis 2017

Present and future of ART in Latin America | Carlos Beltrán, MD

Mark Nelson

MD, MBBS, FRCP

Andean Pacific Workshop on HIV & Hepatitis 2017

Do we really need new drugs? | Mark Nelson, MD

EMB

Ernesto Martinez Buitrago

Andean Pacific Workshop on HIV & Hepatitis 2017

The aging HIV infected patient - neurological issues - poly pharmacy | Ernesto Martinez Buitrago, MD

Isabel Cassetti

Andean Pacific Workshop on HIV & Hepatitis 2017

HIV in Women - PTMCT - pregnancy | Isabel Cassetti, MD

Francesca Ceccherini-Silberstein

PhD

Andean Pacific Workshop on HIV & Hepatitis 2017

Strategies for hepatitis C elimination | Francesca Ceccherini– Silberstein, PhD

Mark Nelson

MD, MBBS, FRCP

Andean Pacific Workshop on HIV & Hepatitis 2017

Implementation of DAAs in clinical management | Mark Nelson, MD

Andean Pacific Workshop on HIV & Hepatitis 2017

Local situation in LA (epidemiology / treatment options) | Jorge Contreras, MD

Susana Cabrera

Andean Pacific Workshop on HIV & Hepatitis 2017

Early diagnosis & testing | Susana Cabrera, MD

Francesca Ceccherini-Silberstein

PhD

Andean Pacific Workshop on HIV & Hepatitis 2017

Clinical Implications of low level viremia/ failure and resistance | Francesca Ceccherini– Silberstein, PhD

APCdlT

Ana Paulina Celi de la Torre

Andean Pacific Workshop on HIV & Hepatitis 2017

Difficult to reach populations in Latin America | Ana Paulina Celi de la Torre, MD

Alejandro Afani

Andean Pacific Workshop on HIV & Hepatitis 2017

WHO Target 90-90-90 : Achievable for Latin America | Alejandro Afani, MD

Marcelo Wolff

MD, FACP, FIDSA